BR9404991A - Processos para aumentar a produção de proteína C e para aumentar o nível de gama-carboxiliação de uma molécula de proteína C - Google Patents

Processos para aumentar a produção de proteína C e para aumentar o nível de gama-carboxiliação de uma molécula de proteína C

Info

Publication number
BR9404991A
BR9404991A BR9404991A BR9404991A BR9404991A BR 9404991 A BR9404991 A BR 9404991A BR 9404991 A BR9404991 A BR 9404991A BR 9404991 A BR9404991 A BR 9404991A BR 9404991 A BR9404991 A BR 9404991A
Authority
BR
Brazil
Prior art keywords
protein
increase
gamma
molecule
processes
Prior art date
Application number
BR9404991A
Other languages
English (en)
Inventor
Brian William Grinnell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9404991A publication Critical patent/BR9404991A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6464Protein C (3.4.21.69)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9404991A 1993-12-15 1994-12-14 Processos para aumentar a produção de proteína C e para aumentar o nível de gama-carboxiliação de uma molécula de proteína C BR9404991A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/168,035 US5618714A (en) 1993-12-15 1993-12-15 Methods for producing protein C

Publications (1)

Publication Number Publication Date
BR9404991A true BR9404991A (pt) 1995-08-08

Family

ID=22609820

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9404991A BR9404991A (pt) 1993-12-15 1994-12-14 Processos para aumentar a produção de proteína C e para aumentar o nível de gama-carboxiliação de uma molécula de proteína C

Country Status (28)

Country Link
US (1) US5618714A (pt)
EP (1) EP0658626B1 (pt)
JP (1) JP3662614B2 (pt)
KR (1) KR950018454A (pt)
CN (1) CN1107887A (pt)
AT (1) ATE196165T1 (pt)
AU (1) AU687914B2 (pt)
BR (1) BR9404991A (pt)
CA (1) CA2138101A1 (pt)
CO (1) CO4340654A1 (pt)
CZ (2) CZ315794A3 (pt)
DE (1) DE69425809T2 (pt)
DK (1) DK0658626T3 (pt)
ES (1) ES2149244T3 (pt)
FI (1) FI106385B (pt)
GR (1) GR3034909T3 (pt)
HU (1) HU219508B (pt)
IL (1) IL111983A0 (pt)
NO (1) NO944846L (pt)
NZ (1) NZ270140A (pt)
PE (1) PE42695A1 (pt)
PL (1) PL176381B1 (pt)
PT (1) PT658626E (pt)
RU (1) RU2110574C1 (pt)
SI (1) SI0658626T1 (pt)
UA (1) UA26870C2 (pt)
YU (1) YU73494A (pt)
ZA (1) ZA949981B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19724543A1 (de) * 1997-06-11 1998-12-17 Philips Patentverwaltung Wechsler-Gerät für Informationsplatten
ES2309167T3 (es) 2001-02-19 2008-12-16 Merck Patent Gmbh Metodo para identificar epitotes de celulas t y metodo para preparar moleculas con inmunogenicidad reducida.
AU2003226012B2 (en) 2002-03-29 2007-05-24 Merck Sharp & Dohme Corp. Methods of virus production
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
CA2574598A1 (en) * 2004-07-23 2006-02-09 The University Of Rochester Activated protein c inhibits undesirable effects of plasminogen activator in the brain
US20090148458A1 (en) * 2005-06-23 2009-06-11 The University Of British Columbia Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy
WO2007140625A1 (en) * 2006-06-09 2007-12-13 The University Of British Columbia Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
US20110171200A1 (en) * 2008-01-15 2011-07-14 Walley Keith R Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound
WO2012068519A2 (en) 2010-11-19 2012-05-24 Sirius Genomics Inc. Markers associated with response to activated protein c administration, and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US4968626A (en) * 1985-08-15 1990-11-06 Board Of Reagents Of The University Of Washington DNA sequence coding for protein C
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
EP0245949B1 (en) * 1986-04-09 1997-10-29 Eli Lilly And Company A method of using eukaryotic expression vectors comprising the bk virus enhancer
AU8339187A (en) * 1986-11-17 1988-06-16 New England Medical Center Hospitals, Inc., The Enhancing gamma-carboxylation of recombinant vitamin k-dependent proteins
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
ZA889497B (en) * 1987-12-28 1990-08-29 Lilly Co Eli Vectors and compounds for expression of zymogen forms of human protein c
JPH0246296A (ja) * 1988-08-09 1990-02-15 Hoechst Japan Ltd 雑種プロテインc及びその製造方法
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
CA1332049C (en) * 1988-10-07 1994-09-20 Eli Lilly And Company Eukaryotic expression
DE69004964T2 (de) * 1989-08-11 1994-03-24 Zymogenetics Inc Zellenzuchtverfahren für die produktion von aktiviertem protein-c.
IL97312A (en) * 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
CA2078667A1 (en) * 1991-01-29 1992-07-30 Masahiko Suzuki Human protein c expression vector

Also Published As

Publication number Publication date
HUT69979A (en) 1995-09-28
JP3662614B2 (ja) 2005-06-22
HU9403600D0 (en) 1995-02-28
CN1107887A (zh) 1995-09-06
NZ270140A (en) 1996-05-28
FI945877A (fi) 1995-06-16
ES2149244T3 (es) 2000-11-01
KR950018454A (ko) 1995-07-22
SI0658626T1 (en) 2001-02-28
JPH07222589A (ja) 1995-08-22
CZ315794A3 (en) 1995-10-18
NO944846L (no) 1995-06-16
CA2138101A1 (en) 1995-06-16
ATE196165T1 (de) 2000-09-15
AU687914B2 (en) 1998-03-05
HU219508B (hu) 2001-04-28
EP0658626B1 (en) 2000-09-06
FI106385B (fi) 2001-01-31
RU94043769A (ru) 1997-03-27
AU8045294A (en) 1995-06-22
IL111983A0 (en) 1995-03-15
US5618714A (en) 1997-04-08
CZ290724B6 (cs) 2002-10-16
PT658626E (pt) 2001-01-31
RU2110574C1 (ru) 1998-05-10
DE69425809T2 (de) 2001-02-01
PL176381B1 (pl) 1999-05-31
CO4340654A1 (es) 1996-07-30
GR3034909T3 (en) 2001-02-28
EP0658626A1 (en) 1995-06-21
DK0658626T3 (da) 2000-10-16
YU73494A (sh) 1997-03-07
ZA949981B (en) 1996-06-14
DE69425809D1 (de) 2000-10-12
FI945877A0 (fi) 1994-12-14
PE42695A1 (es) 1995-12-12
NO944846D0 (no) 1994-12-14
PL306291A1 (en) 1995-06-26
UA26870C2 (uk) 1999-12-29

Similar Documents

Publication Publication Date Title
NO975674L (no) Fremgangsmåte for å regulere sialyleringen av proteiner fremstilt av pattedyrceller i kultur
BR9911549A (pt) Processo de produção de fitase em levedura
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DE3851035T2 (de) Interleukin-7.
BR9404991A (pt) Processos para aumentar a produção de proteína C e para aumentar o nível de gama-carboxiliação de uma molécula de proteína C
PT87887A (pt) Processo para a producao de novos polipeptidos de calicreina derivados por tecnicas de recombinacao
DE69016508T2 (de) Interleukin-7-Rezeptoren.
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
ATE330003T1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
DK638187D0 (da) Hybridproteiner
ES2061719T3 (es) Proceso para la produccion de proteinas.
Righetti et al. Charge heterogeneity of recombinant pro-urokinase and urinary urokinase, as revealed by isoelectric focusing in immobilized pH gradients
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
ATE288476T1 (de) Herstellung von proteinen
KR960017848A (ko) 인간 적혈구 형성 자극 인자의 신규 제조 방법

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal